Resolute System    

Log In
 
 

Forgot Your Password?
 


Not a member? Click here!

Contrast Nephropathy recommendations
New Antiplatelet Agents
New Strategies and Devices to Manage Cardiogenic Shock
The Predictive Value of Computed Tomography Calcium Scores: A Comparison with Quantitative Volumetric Intravascular Ultrasound
Will Cangrelor Replace Clopidogrel and IIb IIIa Inhibitors in the Lab








 

 

Height Influences Risk of CAD (C Nelson, et al. NEJM 2015 Online)

The mechanism underpinning the relationship between height and the risk of CAD is unknown. A genetic-based study has identified an association between shorter height and increased risk of CAD. This association is linked to adverse lipid profile and overlapping genetic pathways involved in development and atherosclerosis.

For more, click here

 

 

 

Lipid Lowering Benefits Both Sexes

The efficacy of statins in men versus women is unclear. A meta-analysis of 27 studies comparing statin efficacy upon major vascular events, major coronary events, stroke, coronary revascularization, and mortality has indicated that both men and women derive similar benefits with statin therapy.


For more, click here

 

 

 

 

Weight and the Risk of Dementia

The association between body weight and risk of dementia remains a subject of debate. A retrospective study of 1,958,191 individuals derived from the UK Clinical Practice Research Datalink has indicated that as compared with a healthy weight, underweight individuals had a 34% higher risk of dementia. In addition, very obese people had a 29% lower risk of dementia.

For more, click here

 

 

 

Total Abandonment of Thrombectomy in STEMI

Manual thrombectomy in patients presenting with STEMI has been proposed to reduce distal embolization and improve clinical outcomes. The TOTAL study of 10,732 STEMI patients has indicated that such an approach does not reduce the risk of CV death, recurrent MI, cardiogenic shock, or heart failure within 180 days. Thrombectomy was also associated with an increased rate of stroke within 30 days.

For more, click here

 

<
||
>













CRT2013
 
Strokes in TAVR Is it a Deal Breaker?
- Samir Kapadia, MD
CoreValve US Pivotal Trial
- John V. Conte, MD
Myocardial infarction with no obstructive coronary atherosclerosis
- Giampaolo Niccoli, MD, PhD
Incidence, Predictors, and Prognostic Impact of Late Bleeding (≥30 days) Complications after Transcatheter Aortic Valve Replacement (TAVR)
- Philippe Généreux, MD
Minimizing Femoral Artery Access Complications during PCI
- Michael S. Lee, MD


Live Case Demonstration from Kusatsu Heart Center
Osamu Hatoh, MD
Treating CTO via Radial?
Richard R. Heuser, MD
Patient Selection for CTO Recanalization: What Are the Appropriate Criteria?
Tarek Helmy, MD
Treating CTOs: Is There Enough Evidence-Based Data or do We Need Further Randomized Clinical Trials?
Gerald S. Werner, MD, PhD
Indication for CTO PCI: Clinical Rationale and Appropriateness
J. Aaron Grantham, MD
 Click here to visit the WEBEX archives


Genetically Determined Height and Coronary Artery Disease.
C Nelson, et al.
NEJM 2015 Online
Randomized Trial of Primary PCI With or Without Routine Manual Thrombectomy.
S Jolly, et al.
NEJM 2015; 372:1389-1398
Surgical Ablation of Atrial Fibrillation during Mitral-Valve Surgery.
A Gillinov, et al.
NEJM 2015; 372:1399-1409
Effects of Red-Cell Storage Duration on Patients Undergoing Cardiac Surgery.
M Steiner, et al.
NEJM 2015; 372:1419-1429
Oral Anticoagulation, Aspirin, or No Therapy in Patients With Nonvalvular AF With 0 or 1 Stroke Risk Factor Based on the CHA2DS2-VASc Score.
G Lip, et al.
JACC 2015; 65:1385-1394
Readmissions After Carotid Artery Revascularization in the Medicare Population.
M Al-Damluji, et al.
JACC 2015; 65:1398-1408
Association of Spontaneous Bleeding and Myocardial Infarction With Long-Term Mortality After Percutaneous Coronary Intervention.
D Kazi, et al.
JACC 2015; 65:1411-1420
Exposure to Parental Smoking in Childhood Is Associated With Increased Risk of Carotid Atherosclerotic Plaque in Adulthood: The Cardiovascular Risk in Young Finns Study.
H West, et al.
Circ 2015; 131:1239-1246
Optimal Medical Therapy Improves Clinical Outcomes in Patients Undergoing Revascularization With Percutaneous Coronary Intervention or Coronary Artery Bypass Grafting: Insights From the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) Trial at the 5-Year Follow-Up.
J Iqbal, et al.
Circ 2015; 131:1269-1277
Efficacy of Folic Acid Therapy in Primary Prevention of Stroke Among Adults With Hypertension in China: The CSPPT Randomized Clinical Trial.
Y Huo, et al.
JAMA 2015; 313:1325-1335
BMI and Risk of Dementia in Two Million People Over Two Decades: A Retrospective Cohort Study.
N Qizilbash, et al.
The Lancet Diabetes & Endocrinology 2015 Online
Efficacy and Safety of LDL-Lowering Therapy Among Men and Women: Meta-Analysis of Individual Data From 174?000 Participants in 27 Randomised Trials.
CTT Collaboration.
The Lancet 2015; 385:1397-1405



Poll Archives
CoreValve US Pivotal Trial - Transcatheter Aortic Valve Replacement or Surgical Aortic Valve Replacement in Patients With Prior Coronary Artery Bypass Grafting
John V. Conte, M.D.
DEFLECT III Trial
Alexandra Lansky, M.D.
The REGULATE-PCI Randomized Clinical Trial
Roxana Mehran, M.D.
PEGASUS Trial
Marc S. Sabatine, M.D., M.P.H.
Promise Trial
Pamela S. Douglas, M.D.
CoreValve US Pivotal Trial - 2-Year Outcomes
Michael J Reardon, M.D., F.A.C.C.
TOTAL Trial
Sanjit Jolly, M.D.
LEGACY STUDY
Rajeev K. Pathak, M.D.
(PROMISE) Trial: Economic Outcomes
Daniel B. Mark, M.D., M.P.H.
Drug-Resistant Hypertension in an Asian Population
Byeong-Keuk Kim, M.D.
Reduced Blood Pressure Lowering Effect of Catheter-Based Renal Denervation in Patients with Isolated Systolic Hypertension: Data from Pooled SYMPLICITY HTN Trials
Felix Mahfoud, M.D.
BEST Trial
Seung-Jung Park, M.D., PhD
Outcomes of the Initial Experience with Commercial Transcatheter Mitral Valve Repair in the U.S.
Paul Sorajja, M.D.
Clinical and Echocardiographic Outcomes at 30 Days with the SAPIEN 3 TAVR System in Inoperable, High-Risk and Intermediate-Risk AS Patients
Susheel Kodali, M.D.
MATRIX
M. Valgimigli, M.D., PhD
EMBRACE STEMI
C. Michael Gibson, M.S., M.D.
Five-Year Outcomes after Randomization to Transcatheter or Surgical Aortic Valve Replacement: Final Results of The PARTNER 1 Trial
Michael J. Mack, M.D.
Relation Between Frailty and Outcomes After Transcatheter Aortic Valve Replacement
Philip Green, M.D.
Effect of the PCSK9 Inhibitor Evolocumab on Cardiovascular Outcomes
Marc S. Sabatine, M.D., M.P.H.

Complex Patients Today and Tomorrow: Medtronic DES solutions from Resolute Integrity to bioresorbable stents
Prof. Sigmund Silber, MD
First Report on the Pivotal DESolve Nx trial: 6-month Clinical and Multimodality Imaging Results
Alexandre Abizaid, MD, PhD
One-Year Outcomes in 1010 Unselected Patients Treated with the PROMUS Element Everolimus-Eluting Stent: The Multicenter PROMUS Element European Post-Approval Surveillance Study
Raul Moreno, MD, et al.
Two-year clinical outcomes in the EVOLVE FHU trial
Ian Meredith, MD, PhD
BIOFLOW-II Trial
Stephan Windecker, MD, et al.

Outcomes in More Than 7000 Patients With Diabetes After Implantation of the Resolute Zotarolimus-eluting Stent
Rosli Mohd Ali, MD
Safety update and long-term clinical outcomes from all studies in the RESOLUTE Global Clinical Program
Carlo Di Mario, MD
Final Five-year Outcomes from the Randomized Comparison of Zotarolimus-eluting Stents With Everolimus-eluting Stents in the RESOLUTE All Comers Trial
Stephan Windecker, MD
Angina Status & TLF Creep: Bioabsorbable Stents (BAS) & Drug-Eluting Stents (DES)
Medtronic, Inc.
Clinical outcomes associated with dual antiplatelet therapy interruption following implantation of the ResoluteTM zotarolimus-eluting stent
Stephan Windecker, MD
Four-year Outcomes from the Randomized Comparison of a Zotarolimus-eluting and an Everolimus-eluting Stent in the RESOLUTE All Comers Trial
Patrick W Serruys MD, PhD
Resolute in Bifurcation Lesions: Data from the RESOLUTE Clinical Program
Prof. Ran Kornowski, MD



4/9/2015
First US commercial procedures with the Watchman device

4/9/2015
Medtronic announces SPYRAL HTN global clinical trial programme for renal denervation

4/9/2015
CoreValve receives first TAVR valve-in-valve indication

4/1/2015
First Commercial Procedures in the United States Performed With Boston Scientific’s Watchman Device

4/1/2015
The Medicines Company’s Cangrelor Approved in Europe

4/1/2015
New Indication Allows Brilinta to Be Crushed for Patients With Difficulty Swallowing

4/1/2015
Medtronic’s CoreValve TAVR System Approved in Japan

4/1/2015
FDA Approves Valve-in-Valve Procedures With CoreValve TAVR System

3/31/2015
Medtronic CoreValve® System Receives FDA Approval for Transcatheter Valve-In-Valve Procedures

3/25/2015
ABIOMED IMPELLA 2.5 RECEIVES FDA APPROVAL FOR ELECTIVE AND URGENT HIGH RISK PERCUTANEOUS CORONARY INTERVENTION (PCI) PROCEDURES

3/18/2015
Infraredx Launches Advanced TVC Imaging System and TVC Muller Extended Bandwidth NIRS-IVUS Catheter

3/18/2015
Medtronic Initiates Pivotal Studies of Resolute Onyx(TM) Drug-Eluting Stent in United States

3/18/2015
Toshiba’s Infinix 4DCT Receives FDA Clearance with Aquilion PRIME CT Configuration

3/18/2015
Boston Scientific Announces Definitive Agreement To Acquire American Medical Systems' Urology Portfolio For Up To $1.65 Billion

3/10/2015
Penumbra Launches POD Embolization Anchoring Device at SIR

3/10/2015
Boston Scientific to Acquire American Medical Systems’ Urology Portfolio

3/10/2015
ArtVentive Introduces EOS Device in the United States

3/10/2015
Vascutek to Distribute Vascular Flow Technologies’ Spiral Flow Grafts in Europe

3/10/2015
Cardinal Health to Acquire Cordis

12/18/2014
Teleflex Awarded Dialysis Agreement With Premier

12/18/2014
Merit Medical’s One Snare System Cleared by FDA
ACS & AMI
Angiomyogenesis & Cell Therapy
Carotid Interventions

Home | CRT2015 | CardioTube | Interesting Cases | Trials | Weekly Poll Archive | Newsletter Archive | Login


Copyright © 2015, CRTONLINE - About / Contact Us. All rights reserved. Privacy Policy
Powered by Multiweb